Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
A Study of TY-2136b in Patients With Advanced Solid Tumors Harboring ALK, ROS1 or NTRK1-3 Alterations
Apply
TY-2136b
A Study of TY-2136b in Patients With Advanced Solid Tumors Harboring ALK, ROS1 or NTRK1-3 Alterations
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step